New study stirs up semglutide and suicide link debate
HQ Team August 22, 2024: A new study based on data from the World Health Organization’s records on adverse drug reactions found that.
Drugs
Health
Pharma
Drugs
Health
Pharma
Diabetes and weight loss drug can help quit smoking, finds new study
HQ Team July 31, 2024: A new research published in the Annals of Internal Medicine reveals that semaglutide is effective in helping people quit.
Drugs
Health
Pharma
FDA issues warning over weight-loss drug overdose, dosing errors
Overdose of weight-loss drugs and dosing errors by patients and healthcare providers have led to adverse events, including hospitalisation, the USFDA warned.
Drugs
Health
Pharma
7-fold increase in use of GLP-1 weight loss drugs among teens, young adults
Research finds a sharp increase in use of weightloss drugs such as Ozempic and Wegovy among teens and young adults
Drugs
Health
Pharma
Novo Nordisk says Ozempic reduces kidney disease progression
HQ Team March 6, 2024: Novo Nordisk’s diabetes drug Ozempic delayed the progression of kidney disease and cardiovascular and kidney death in 24%.
Drugs
Health
Pharma
Novo Nordisk stops testing of Ozempic as kidney trial meets efficacy goals
HQ Team October 11, 2023: Dutch pharmaceutical company, Novo Nordisk, has stopped testing Ozempic to treat the progression of renal impairment in people.
Drugs
Health
Pharma
Users of diabetic drugs for weight loss at risk of stomach paralysis
HQ Team October 7, 2023: Diabetes drugs used in weight-loss therapies may come with a risk of stomach paralysis, pancreatitis and bowel obstruction,.